[
  {
    "Index": "1",
    "Result": []
  },
  {
    "Index": "2",
    "Result": []
  },
  {
    "Index": "3",
    "Result": [
      {
        "evidence": "Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.",
        "bel_statement": "act(p(HGNC:MTOR), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Similarly, mTOR, p38, MEK1 and DYRK2 all phosphorylated S326 but AKT1 was the most potent activator.",
        "bel_statement": "act(p(HGNC:DYRK2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))"
      },
      {
        "evidence": "Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))"
      }
    ]
  },
  {
    "Index": "4",
    "Result": [
      {
        "evidence": "Consistent with our previous findings, AKT1 strongly induced HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases act(p(HGNC:HSF1))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT1), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      }
    ]
  },
  {
    "Index": "5",
    "Result": [
      {
        "evidence": "AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",
        "bel_statement": "act(p(HGNC:AKT2), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      },
      {
        "evidence": "mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.",
        "bel_statement": "act(p(HGNC:MTOR), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))"
      }
    ]
  },
  {
    "Index": "6",
    "Result": [
      {
        "evidence": "Introduction of AKT1 was observed to promote a significant increase in trimerization, although the AKT1-driven trimerization was not as much as heat stress.",
        "bel_statement": "p(HGNC:AKT1) directlyIncreases complex(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization.",
        "bel_statement": "p(HGNC:AKT2) directlyIncreases complex(p(HGNC:HSF1))"
      },
      {
        "evidence": "AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization.",
        "bel_statement": "p(HGNC:AKT3) directlyIncreases complex(p(HGNC:HSF1))"
      },
      {
        "evidence": "Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding.",
        "bel_statement": "p(HGNC:AKT1) directlyIncreases act(p(HGNC:HSF1), ma(GO:DNA binding))"
      },
      {
        "evidence": "Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms.",
        "bel_statement": "p(HGNC:AKT1) directlyIncreases r(HGNC:HSPA1A)"
      },
      {
        "evidence": "Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms.",
        "bel_statement": "p(HGNC:AKT1) directlyIncreases r(FPLX:HSP90)"
      }
    ]
  },
  {
    "Index": "7",
    "Result": []
  },
  {
    "Index": "8",
    "Result": [
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "p(HGNC:NOS2) increases a(CHEBI:3-nitrotyrosine)"
      },
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "act(p(HGNC:NOS2)) increases act(a(CHEBI:NADPH))"
      },
      {
        "evidence": "Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity, activation of extracellular-regulated kinase (ERK), c-Jun terminal kinase (JNK) and Janus kinase (Jak2), and degradation of IkB in microvascular endothelial cells exposed to pro-inflammatory stimulus [lipopolysaccharide (LPS) + interferon g (IFNg)] and on vascular permeability in air pouches of mice injected with LPS + IFNg.",
        "bel_statement": "act(p(HGNC:JAK2)) directlyIncreases bp(GO:catabolic process)"
      }
    ]
  },
  {
    "Index": "9",
    "Result": [
      {
        "evidence": "The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).",
        "bel_statement": "complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(HGNC:ERCC5), p(FPLX:RPA))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1))"
      },
      {
        "evidence": "This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.",
        "bel_statement": "complex(p(HGNC:ERCC5), p(HGNC:XPA))"
      }
    ]
  },
  {
    "Index": "10",
    "Result": []
  },
  {
    "Index": "11",
    "Result": [
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:DYRK1A), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))"
      },
      {
        "evidence": "Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.",
        "bel_statement": "act(p(HGNC:DYRK3), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))"
      },
      {
        "evidence": "AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.",
        "bel_statement": "act(p(FPLX:AMPK), ma(GO:\"kinase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 344))"
      },
      {
        "evidence": "In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.",
        "bel_statement": "act(p(HGNC:SETD7), ma(GO:\"methyltransferase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 233))"
      },
      {
        "evidence": "In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.",
        "bel_statement": "act(p(HGNC:SETD7), ma(GO:\"methyltransferase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 235))"
      },
      {
        "evidence": "In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.",
        "bel_statement": "act(p(HGNC:SETD7), ma(GO:\"methyltransferase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 236))"
      },
      {
        "evidence": "In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.",
        "bel_statement": "act(p(HGNC:SETD7), ma(GO:\"methyltransferase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 238))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "act(p(HGNC:SUMO1), ma(GO:\"SUMO transferase activity\")) directlyIncreases p(HGNC:SIRT1, pmod(Sumo, Lys, 734))"
      },
      {
        "evidence": "Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",
        "bel_statement": "act(p(HGNC:SENP1), ma(GO:\"protein desumoylation\")) directlyDecreases p(HGNC:SIRT1, pmod(Sumo, Lys, 734))"
      },
      {
        "evidence": "Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1\u03b1 transcriptional activity.",
        "bel_statement": "p(HGNC:GAPDH) directlyIncreases p(HGNC:SIRT1, pmod(NO, Cys, 387))"
      },
      {
        "evidence": "Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1\u03b1 transcriptional activity.",
        "bel_statement": "p(HGNC:GAPDH) directlyIncreases p(HGNC:SIRT1, pmod(NO, Cys, 390))"
      }
    ]
  },
  {
    "Index": "12",
    "Result": [
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT1) localizes bp(GO:nucleus)"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT6) localizes bp(GO:nucleus)"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT7) localizes bp(GO:nucleus)"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT2) localizes bp(GO:cytoplasm)"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT3) localizes bp(GO:mitochondrion)"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT4) localizes bp(GO:mitochondrion)"
      },
      {
        "evidence": "Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.",
        "bel_statement": "p(HGNC:SIRT5) localizes bp(GO:mitochondrion)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT1), ma(GO:\"deacetylase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT5), ma(GO:\"deacetylase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT4), ma(GO:\"ADP-ribosyltransferase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT6), ma(GO:\"ADP-ribosyltransferase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT2), ma(GO:\"deacetylase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT2), ma(GO:\"ADP-ribosyltransferase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT3), ma(GO:\"deacetylase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 and SIRT5 are primarily protein deacetylases, SIRT4 and SIRT6 are mono(ADP)-ribosyltransferases, and SIRT2 and SIRT3 exhibit both enzymatic activities; no clear functionality has been attributed to SIRT7.",
        "bel_statement": "act(p(HGNC:SIRT3), ma(GO:\"ADP-ribosyltransferase activity\")) increases a(CHEBI:ADP)"
      },
      {
        "evidence": "SIRT1 has been implicated in signaling pathways underlying various diseases, including: diabetes, cardiovascular disease, neurodegeneration, cancer, aging, and obesity.",
        "bel_statement": "act(p(HGNC:SIRT1), ma(GO:nucleic acid binding transcription factor activity)) depends a(CHEBI:NAD(+))"
      }
    ]
  },
  {
    "Index": "13",
    "Result": [
      {
        "evidence": "...deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "p(HGNC:MAP3K7) directlyDecreases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "...deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).",
        "bel_statement": "p(HGNC:IKBKG) directlyDecreases bp(GO:\"apoptotic process\")"
      },
      {
        "evidence": "Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)...",
        "bel_statement": "p(HGNC:TNF) directlyIncreases p(FPLX:NFkappaB)"
      },
      {
        "evidence": "Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)...",
        "bel_statement": "p(HGNC:TNF) directlyIncreases p(FPLX:JNK)"
      }
    ]
  },
  {
    "Index": "14",
    "Result": [
      {
        "evidence": "Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis.",
        "bel_statement": "p(HGNC:TNF) association act(p(FPLX:NFkappaB))"
      }
    ]
  },
  {
    "Index": "15",
    "Result": [
      {
        "evidence": "A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation",
        "bel_statement": "p(HGNC:TNFAIP3) directlyDecreases p(HGNC:MAP3K5)"
      },
      {
        "evidence": "ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated",
        "bel_statement": "p(HGNC:MAP3K5) increases p(FPLX:JNK)"
      },
      {
        "evidence": "We here showed that TNF affects the interaction between A20 and ASK1, which could explain the ASK1-dependent phosphorylation of JNK at specific periods after TNF administration",
        "bel_statement": "p(HGNC:TNF) regulates complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))"
      }
    ]
  },
  {
    "Index": "16",
    "Result": [
      {
        "evidence": "Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.",
        "bel_statement": "complex(p(FPLX:C1), p(FPLX:C1q), p(HGNC:C1R)) directlyIncreases act(p(HGNC:C4A), ma(GO:\"cleaving activity\"))"
      },
      {
        "evidence": "The complex of C4b and C2a (C4b2a) is a serine protease that specifically cleaves C3 into the anaphylatoxin C3a and the active form of C3, C3b, which is then able to covalently bind to the cell surfaces.",
        "bel_statement": "complex(p(HGNC:C4B), p(HGNC:C2)) directlyIncreases act(p(HGNC:C3), ma(GO:\"cleaving activity\"))"
      }
    ]
  },
  {
    "Index": "17",
    "Result": [
      {
        "evidence": "For example, in the fluid phase, factor H can bind to C3b, preventing the formation of the C3 convertase.",
        "bel_statement": "p(HGNC:CFH) directlyDecreases act(p(HGNC:C3))"
      },
      {
        "evidence": "Once bound to see C3b, factor H serves as a co-factor, allowing another compliment protein, factor I, to cleave C3b, thus inactivating it.",
        "bel_statement": "complex(p(HGNC:CFH), p(HGNC:C3)) => act(p(HGNC:CFI))"
      }
    ]
  },
  {
    "Index": "18",
    "Result": [
      {
        "evidence": "Li and coworkers demonstrated that partial sciatic nerve ligation activated complement.",
        "bel_statement": "a(GO:'complement activation') increases p(HGNC:C3)"
      }
    ]
  },
  {
    "Index": "19",
    "Result": [
      {
        "evidence": "In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",
        "bel_statement": "p(HGNC:SLAMF1) regulates p(HGNC:TLR4)"
      },
      {
        "evidence": "We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1.",
        "bel_statement": "complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))"
      }
    ]
  },
  {
    "Index": "20",
    "Result": [
      {
        "evidence": "This results in an immediate activation of nuclear factor kappaB (NF-kappaB) and production of proinflammatory cytokines.",
        "bel_statement": "p(HGNC:TLR4) directlyIncreases p(FPLX:NFkappaB)"
      }
    ]
  }
]